incid
pneumonia
increas
exact
annual
incid
pneumonia
difficult
determin
notifi
diseas
incid
vari
geographi
popul
demograph
comorbid
condit
sever
flu
season
approxim
million
case
communityacquir
pneumonia
least
case
hospitalacquir
pneumonia
report
annual
pneumonia
account
largest
mortal
common
infecti
diseas
pneumonia
rank
top
seven
among
major
lead
caus
death
adult
usa
fourth
lead
caus
death
us
elderli
popul
larg
varieti
organ
caus
pneumonia
tabl
import
complic
pneumonia
includ
abscess
format
pleural
effus
empyema
format
bacteremia
sepsi
septic
shock
acut
respiratori
distress
syndrom
ard
mening
endocard
multipl
organ
dysfunct
failur
rapid
initi
broadspectrum
empir
antibiot
therapi
correl
longterm
morbid
mortal
pneumonia
earlier
specif
infecti
agent
appropri
treat
better
outcom
like
center
diseas
control
cdc
defin
pneumonia
present
chest
radiograph
reveal
new
progress
infiltr
pleural
effus
cavit
one
follow
chang
charact
quantiti
consist
sputum
pathogen
isol
lower
respiratori
tract
cultur
lung
biopsi
viru
viral
antigen
isol
respiratori
secret
diagnost
serum
igm
antibodi
titer
fourfold
rise
igg
antibodi
titer
demonstr
pair
serum
sampl
histolog
evid
pneumonia
demonstr
tissu
biopsi
note
gener
criteria
includ
sputum
gram
stain
cultur
pneumonia
treatment
simplifi
numer
guidelin
describ
standard
medic
care
manag
pneumonia
evolv
consider
last
decad
base
larg
multicent
outcom
studi
present
evidencebas
seriou
infect
treat
medic
emerg
antibiot
must
initi
soon
possibl
delay
obtain
cultur
await
cultur
sensit
data
approach
base
bestpractic
data
regard
diagnosi
risk
stratif
antibiot
manag
protocol
howev
evolv
pattern
antibiot
resist
emerg
pathogen
new
antibiot
requir
continu
reassess
exist
guidelin
also
suffici
variabl
hospit
requir
individu
therapi
base
local
institut
antibiogram
data
clear
genet
compon
risk
pneumonia
sepsi
genet
polymorph
molecul
import
antigen
recognit
bind
mannosebind
lectin
tolllik
receptor
well
inflammatori
mediat
tumor
necrosi
factor
famili
angiotensin
convert
enzym
like
pharmacolog
signific
great
mani
noninfecti
diseas
caus
febril
pneumon
mimic
pneumonia
includ
eosinophil
pneumonia
interstiti
lung
diseas
associ
connect
tissu
disord
vascul
pulmonari
airway
diseas
neoplasm
sarcoidosi
ard
exposur
inhal
gase
toxin
radiat
pneumon
cytotoxin
therapi
pulmonari
infarct
noncytotox
pharmacolog
agent
mimic
pneumonia
includ
antimicrobi
agent
phenytoin
amiodaron
narcot
aspir
pneumon
mendelson
syndrom
occur
follow
aspir
acid
gastric
content
may
present
lobar
infiltr
progress
gener
pneumon
figur
antibiot
therapi
indic
initi
treatment
aspir
pneumon
gener
typic
present
pneumonia
system
inflammatori
respons
syndrom
sir
evid
widen
arteriolaralveolar
oxygen
diffus
gradient
histori
physic
examin
microbiolog
serolog
studi
help
confirm
diagnosi
consolid
right
upper
left
lung
field
accentu
interstiti
mark
earli
alveolar
chang
reflect
evolv
local
inflamm
notabl
distribut
earli
aspir
pneumon
find
depend
patient
posit
time
aspir
need
local
lower
lung
field
risk
factor
determin
virul
sever
pneumonia
relat
pathogen
host
characterist
characterist
pathogen
includ
organ
resist
characterist
virul
dose
inoculum
host
factor
commonli
divid
alter
mucos
integr
impair
immun
mucos
integr
compromis
epitheli
injuri
viral
prime
mechan
injuri
endotrach
tube
repetit
mucos
trauma
result
vigor
tracheal
suction
chemic
injuri
aspir
gastric
content
tobacco
abus
malnutrit
impair
host
immun
may
due
system
immunosuppress
due
infect
malign
malnutrit
liver
renal
failur
diabet
mellitu
exposur
immunosuppress
agent
steroid
chemotherapeut
agent
toxin
pharmaceut
immunosuppress
side
effect
notabl
blood
transfus
demonstr
suppress
system
immun
increas
risk
nosocomi
infect
includ
pneumonia
lung
bodi
organ
largest
epitheli
surfac
area
continu
contact
extern
environ
therefor
vulner
area
approxim
particip
ga
exchang
continu
expos
airborn
inorgan
organ
particl
well
microorgan
pulmonari
infect
caus
inhal
aerosol
inocul
aspir
secret
particul
matter
hematogen
spread
direct
inocul
common
mechan
pneumonia
develop
contamin
nasooropharynx
upper
airway
subsequ
aspir
infect
secret
distal
respiratori
tree
otherwis
healthi
patient
pharyng
secret
bacteri
concentr
approxim
organismsml
therefor
aspir
exceedingli
small
volum
ml
introduc
hightit
bacteri
inoculum
respiratori
tract
patient
incapacit
coexist
diseas
decreas
salivari
flow
decreas
cough
reflex
poor
oral
hygien
occur
intub
mechan
ventil
patient
bacteri
viral
fungal
load
pharyng
secret
greater
virul
therefor
signific
risk
factor
develop
pneumonia
patient
chronic
acut
sinus
postnas
drip
risk
aspir
contamin
nasopharyng
secret
rare
patient
pharyng
pouch
esophag
zenker
diverticuli
sequest
secret
food
particl
may
aspir
sleep
one
caus
contamin
lung
organ
ventil
ventil
circuit
regularli
develop
stagnant
water
condens
becom
rapidli
colon
pathogen
bacteria
water
inadvert
wash
endotrach
tube
pneumonia
result
patient
undergo
elect
surgic
tracheostomi
must
oropharynx
well
suction
prefer
also
decontamin
prior
deflat
endotrach
tube
cuff
larg
number
ventilatorassoci
pneumonia
inadvert
result
aspir
pool
oropharyng
secret
tracheostomi
procedur
epitheli
damag
predispos
success
pathogen
colon
develop
infect
nidu
epitheli
injuri
caus
chronic
acut
lung
diseas
environment
toxin
tobacco
abus
genet
predisposit
antitrypsin
defici
chronic
aspir
syndrom
notabl
mucociliari
clearanc
diminish
smoker
prior
infect
mycoplasma
pneumonia
virus
haemophilu
influenza
shown
destroy
cilia
impair
ciliari
function
addit
sir
alter
epitheli
structur
function
presenc
endotrach
tube
demonstr
inhibit
synchron
ciliari
motil
therefor
mucociliari
clearanc
impair
intub
patient
cytolog
studi
demonstr
structur
chang
epitheli
glycoprotein
bind
characterist
mucu
product
ciliari
function
surfact
protein
composit
concentr
extracellular
enzymat
profil
sever
system
ill
thought
provid
critic
initi
link
bacteri
adhes
colon
infect
fibronectin
epitheli
coat
found
normal
mucosa
prevent
gramneg
pathogen
adher
respiratori
epithelium
loss
fibronectin
facilit
bacteri
pneumonia
develop
viral
infect
exampl
hematogen
seed
lung
infect
site
anoth
possibl
develop
pneumonia
infect
prosthes
intravascular
devic
clinic
caveat
aspir
aspir
oropharyng
secret
especi
common
patient
depress
level
conscious
due
intox
sedat
central
nervou
system
dysfunct
disord
deglutit
due
neuromuscular
disord
gastroesophag
reflux
esophag
dysmotil
prolong
nasogastr
intub
also
predispos
aspir
pool
secret
endocard
even
possibl
bacteri
transloc
lumen
ischem
abdomin
viscu
potenti
sourc
secondari
metastat
infect
tumor
compromis
tissu
integr
suppress
immun
tumor
predispos
colon
local
invas
also
import
caus
postobstruct
inspiss
mucu
secret
also
hypothesi
wherebi
bacteria
thought
transloc
gut
lumen
surround
venou
lymphat
plexus
induc
gener
inflamm
bacteremia
term
gut
motor
hypothesi
chest
radiograph
mainstay
radiolog
diagnosi
followup
pneumonia
radiolog
pictur
may
lag
behind
clinic
condit
interobserv
variabl
remain
limit
radiolog
diagnosi
radiolog
appear
hospitaland
ventilatoracquir
pneumonia
difficult
distinguish
atelectasi
howev
serial
radiograph
may
reveal
atelectasi
resolv
rapidli
wide
believ
unproven
patient
hydrat
statu
affect
radiolog
appear
underli
pneumonia
therefor
content
chest
radiograph
dehydr
patient
less
like
reveal
pneumoniarel
infiltr
unreli
although
attract
hypothesi
radiolog
infiltr
may
difficult
identifi
patient
hyperexpand
lung
field
copd
fibrosi
scar
atelectasi
pulmonari
edema
radiolog
appear
pneumonia
tradit
result
gener
classif
base
appear
distribut
alveolar
consolid
may
occur
result
inflammatori
edema
alveolar
segment
consolid
involv
entir
lobe
call
lobar
pneumonia
characterist
lobar
pneumonia
includ
air
bronchogram
volum
loss
mediastin
shift
toward
side
consolid
consolid
pneumonia
frequent
occur
pneumonia
klebsiella
pneumonia
figur
air
bronchogram
demonstr
airsoft
tissu
interfac
especi
help
indirect
delin
consolid
posterior
heart
left
hemithorax
bronchopneumonia
lobular
pneumonia
involv
inflammatori
respons
primarili
site
bronchi
surround
parenchyma
tissu
bronchopneumonia
usual
seen
segment
patchi
infiltr
consist
partial
segment
consolid
consolid
like
local
segment
involv
parenchyma
patchi
bronchopneumonia
lobar
pneumonia
bronchopneumonia
especi
common
pneumon
process
superimpos
underli
chronic
bronchiti
bronchiectasi
bronchopneumonia
commonli
seen
h
influenza
aureu
c
pneumonia
figur
interstiti
pneumonia
also
known
peribronchovascular
infiltr
typic
appear
reticular
reticulonodular
pattern
reflect
inflamm
primarili
local
interstiti
tissu
interstiti
promin
resembl
earli
stage
pulmonari
edema
also
associ
noninfecti
caus
interstiti
lung
diseas
must
includ
differenti
diagnosi
interstiti
pictur
especi
common
pneumonia
p
carinii
atyp
organ
virus
radiolog
appear
mycoplasma
pneumonia
unilater
bilater
lobar
segment
infiltr
show
patchi
confluent
air
space
diseas
sever
case
reveal
diffus
bilater
reticulonodular
pattern
lung
field
figur
nodular
infiltr
typic
welldefin
focal
lesion
greater
cm
chest
radiograph
nodular
infiltr
may
abscess
fungal
tubercul
granuloma
malign
wegen
granulomatosi
necrot
vascular
lesion
accompani
sever
p
aeruginosa
infect
nodular
infiltr
may
suggest
histoplasmosi
tuberculosi
cavit
often
associ
staphylococc
pneumonia
infect
aspergillu
good
correl
radiolog
appear
caus
pathogen
pneumonia
may
accompani
pleural
fluid
collect
known
parapneumon
infiltr
figur
may
resolv
progress
organ
empyema
may
gener
locul
direct
microscop
examin
gramstain
sputum
major
diagnost
valu
gram
stain
inexpens
easili
avail
advantag
immediaci
sputum
gram
stain
help
guid
antibiot
therapi
base
preval
gramposit
gramneg
organ
fals
neg
rate
sputum
cultur
obtain
expector
greater
qualiti
sputum
determin
presenc
epitheli
cell
indic
oropharyng
contamin
presenc
squamou
epitheli
cell
per
lowpow
field
indic
specimen
contamin
oropharyng
secret
presenc
one
macrophag
indic
sputum
sampl
obtain
lower
respiratori
tract
presenc
elastin
fiber
sputum
sampl
smear
prepar
potassium
hydroxid
indic
specimen
obtain
lower
respiratori
tract
also
indic
presenc
necrot
pulmonari
process
presenc
neutrophil
per
lowpow
field
indic
infect
pneumonia
tracheobronch
sputum
plate
infiltr
promin
interstiti
mark
classic
radiograph
interstiti
atyp
pneumonia
process
reveal
accentu
reticular
mark
within
lung
parenchyma
well
septal
kerli
b
line
air
bronchogram
clearli
visibl
bilater
indic
lung
consolid
accentu
airtissu
interfac
hilar
promin
characterist
fluid
meniscu
right
evid
aerat
within
right
lower
lobe
underli
pneumonia
appar
view
could
defin
later
decubitu
view
surround
fluid
layer
away
pulmonari
tissu
cultur
media
determin
innoculum
densiti
coloni
form
unit
cfu
definit
identif
coloni
type
antibiot
suscept
profil
fever
critic
ill
patient
nonspecif
sign
inflamm
alway
reflect
presenc
underli
infect
also
elev
liver
function
test
may
occur
infect
reflect
nonspecif
find
often
associ
legionella
tuberculosi
mycoplasma
q
fever
tularemia
psittacosi
serolog
test
one
import
diagnost
modal
identifi
organ
easili
cultur
tabl
communityacquir
pneumonia
cap
account
medic
intens
care
unit
icu
admiss
approxim
icu
patient
cap
requir
mechan
ventil
incid
cap
approxim
case
per
adult
per
year
usa
account
almost
one
million
hospit
admiss
per
year
cost
treat
cap
exce
billion
per
year
usa
although
approxim
threequart
patient
cap
success
manag
outpati
requir
hospit
account
disproportion
pneumoniarel
health
care
cost
sinc
cost
inpati
manag
pneumonia
exce
cost
outpati
care
least
factor
estim
total
cost
treat
cap
hospitalrel
mean
durat
hospit
cap
day
includ
routin
hospit
well
intens
care
stay
averag
mortal
cap
averag
cap
complic
ard
occur
approxim
patient
cap
mortal
rate
approach
risk
factor
cap
includ
chronic
respiratori
cardiac
diseas
institution
advanc
age
alcohol
addit
dysphagia
sedat
increas
risk
aspir
nonaspir
pneumonia
elderli
popul
risk
factor
mortal
cap
includ
multilobar
infiltr
posit
blood
cultur
rapidli
progress
infiltr
polymicrobi
infect
hypoalbuminemia
renal
insuffici
respiratori
failur
seriou
comorbid
advanc
age
immunosuppress
alter
mental
statu
coma
prolong
mechan
ventil
prevent
may
import
strategi
reduc
impact
cap
especi
vulner
popul
elderli
tobacco
alcohol
abus
cessat
program
may
improv
pulmonari
function
mucu
clearanc
decreas
risk
aspir
nutrit
statu
underrecogn
risk
factor
pneumonia
develop
addit
use
polyval
pneumococc
vaccin
annual
influenza
vaccin
mani
controversi
decreas
hospit
complic
death
streptococc
pneumonia
singl
import
caus
cap
may
also
respons
signific
number
hospitalacquir
pneumonia
pneumonia
case
mortal
approach
among
patient
admit
icu
pneumococc
pneumonia
bacteremia
case
mortal
rate
approach
penicillinresist
pneumonia
prsp
result
configur
chang
penicillinbind
protein
structur
strain
identifi
rate
isol
approach
pneumonia
also
evolv
resist
macrolid
clindamycin
streptogramin
patient
prior
medic
problem
risk
specif
organ
h
influenza
k
pneumonia
especi
common
isol
pneumonia
alcohol
patient
patient
chronic
sputum
cultur
obtain
initi
empir
antibiot
therapi
yield
lower
incid
true
posit
greater
incid
fals
neg
empir
initi
antibiot
therapi
cap
must
provid
effect
coverag
pneumonia
agent
also
cover
legionella
mycoplasma
consid
antibiot
choic
ceftriaxon
cefotaxim
addit
either
macrolid
eg
azithromycin
fluoroquinolon
fine
et
al
use
clinic
investig
metaanalysi
identifi
quantifi
effect
risk
factor
mortal
fine
criteria
describ
tabl
fine
predict
rule
algorithm
applic
fine
criteria
determin
optim
point
care
tabl
blood
cultur
low
yield
recommend
workup
uncompl
cap
hand
sever
cap
especi
pneumococc
origin
bacteremia
import
predictor
mortal
infecti
diseas
societi
america
idsa
american
thorac
societi
at
promulg
guidelin
treatment
cap
tabl
term
atyp
pneumonia
origin
use
describ
clinic
syndrom
pneumonia
differ
clinic
radiolog
typic
pneumococc
pneumonia
sinc
atyp
pathogen
difficult
identifi
gram
stain
cultur
term
atyp
pneumonia
coin
atyp
pneumonia
caus
seriou
clinic
syndrom
high
morbid
mortal
frequent
requir
icu
care
present
diagnost
test
atyp
pathogen
includ
polymeras
chain
reaction
complement
fixat
microimmunofluoresc
enzym
immunoassay
c
pneumonia
pneumonia
other
includ
serum
igm
antibodi
cold
agglutinin
mycoplasma
direct
fluoresc
antibodi
dfa
indirect
immunofluoresc
antibodi
test
legionella
spp
establish
techniqu
complement
fixat
rel
uncompl
low
sensit
fluoresc
techniqu
determin
antibodi
titer
dilut
serum
sampl
subject
costli
enzymelink
immunosorb
assay
elisa
requir
dilut
result
measur
optic
densiti
od
unit
less
subject
urinari
antigen
test
legionella
pneumophilia
serogroup
nonserolog
test
becom
posit
day
ill
may
requir
second
test
convalesc
phase
ill
confirm
diagnosi
confirm
necessari
type
environ
may
play
import
role
organ
patient
expos
patient
immunocompromis
live
shelter
incarcer
especi
high
risk
infect
mycobacterium
tuberculosi
hunter
hallmark
present
atyp
pneumonia
nonproduct
cough
viral
pneumonia
typic
occur
set
outbreak
occur
predominantli
winter
earli
spring
patient
risk
viral
pneumonia
includ
underli
heart
diseas
chronic
pulmonari
diseas
pregnanc
pulmonari
infiltr
occur
young
adult
varicella
frank
pneumonia
present
rare
suggest
bacteri
superinfect
figur
herpet
pneumonia
occur
high
frequenc
postop
cardiac
transplant
patient
true
incid
probabl
underrecogn
rout
infect
probabl
aspir
saliva
contamin
viru
clinic
pictur
usual
limit
hypoxia
dyspnea
viru
may
isol
cultur
treatment
antivir
agent
acyclovir
pulmonari
hantaviru
syndrom
sin
nombr
viru
identifi
american
southwest
acquir
exposur
deer
mous
excrement
contamin
dust
howev
diseas
report
throughout
usa
syndrom
character
nonspecif
prodrom
follow
hypoxemia
sepsi
syndrom
although
clinic
pictur
suggest
pneumonia
microscop
pictur
consist
pulmonari
capillari
leak
syndrom
occur
ard
case
fatal
rate
hantaviru
pulmonari
syndrom
last
two
year
grow
concern
largescal
epidem
viral
pneumonia
one
greatest
impact
sever
acut
respiratori
syndrom
sar
coronaviru
infect
caus
pneumonia
sever
ard
first
recogn
southeast
asia
novemb
spread
countri
repeat
epidem
episod
like
sar
mortal
rate
worldwid
approxim
icu
admiss
rate
rang
icu
patient
requir
mechan
ventilatori
support
mortal
rate
sar
patient
admit
icu
rang
emerg
diseas
like
becom
global
threat
virus
increasingli
jump
speci
mutat
rapidli
fungal
pneumonia
repres
subset
cap
caus
endem
fungi
histoplasma
capsulatum
blastomyc
dermatitidi
coccidioid
immiti
howev
fungal
pneumonia
also
repres
opportunist
infect
immunocompromis
popul
like
import
larg
underdiagnos
pathogen
nosocomi
especi
ventilatorassoci
pneumonia
histoplasma
found
soil
contamin
bird
bat
excreta
histoplasmosi
common
system
mycosi
usa
characterist
found
ohio
mississippi
river
valley
although
estim
peopl
develop
histoplasmosi
usa
annual
less
develop
clinic
symptomat
diseas
immunocompet
individu
intact
tcell
function
infect
usual
subclin
selflimit
patient
develop
symptomat
histoplasmosi
present
usual
flulik
syndrom
nonproduct
cough
pleurit
chest
pain
less
infect
individu
develop
rheumatolog
syndrom
pericard
arthralgia
inflammatori
granulomat
mediastin
patient
impair
immunolog
function
patient
receiv
high
inoculum
exposur
construct
agricultur
worker
may
acut
overwhelm
pulmonari
histoplasmosi
character
profound
hypoxemia
diffus
bilater
pulmonari
infiltr
rare
complic
histoplasmosi
includ
chronic
upper
lobe
cavitari
pneumon
diseas
fibros
mediastin
progress
dissemin
histoplasmosi
definit
diagnosi
usual
requir
immunodiagnost
test
definit
period
acid
schiff
stain
treatment
either
itraconazol
amphotericin
b
concomit
system
corticosteroid
therapi
consid
figur
blastomyc
also
found
moist
soil
rich
decay
organ
materi
blastomycosi
endem
along
mississippi
ohio
river
basin
well
great
lake
approxim
infect
patient
isol
lung
involv
remain
develop
dissemin
lymphohematogen
diseas
involv
primarili
skin
bone
genitourinari
system
pulmonari
blastomycosi
develop
approxim
six
week
exposur
present
flulik
syndrom
product
mucopurul
sputum
chest
radiograph
reveal
nonspecif
diffus
reticulonodular
infiltr
chronic
common
blastomycosi
similar
tuberculosi
accompani
night
sweat
weight
loss
product
cough
may
progress
cavitari
diseas
blastomycosi
diagnos
pa
silver
stain
sputum
ketoconazol
itraconazol
fluconazol
mainstay
therapi
figur
coccidioid
found
semiarid
desert
soil
coccidiomycosi
endem
southwestern
usa
approxim
new
case
occur
annual
sonoran
desert
central
san
joaquin
valley
california
approxim
infect
individu
develop
clinic
evid
diseas
one
three
week
follow
exposur
diseas
typic
selflimit
flulik
pneumon
character
nonproduct
clinic
caveat
sar
common
clinic
symptom
sign
sar
fever
cough
dyspnea
myalgia
malais
common
laboratori
abnorm
includ
mild
leukopenia
lymphopenia
increas
aspart
transaminas
alanin
transaminas
lactic
dehydrogenas
creatin
kinas
chest
radiograph
pattern
rang
focal
infiltr
diffus
airspac
diseas
risk
mortal
increas
advanc
age
comorbid
high
lactic
dehydrogenas
high
neutrophil
count
admiss
pneumonia
adult
cough
pleurit
chest
pain
rheumatolog
complic
occur
patient
radiograph
find
typic
patchi
nodular
infiltr
may
coalesc
mimic
cap
patient
develop
pleural
effus
hilar
adenopathi
patient
develop
chronic
pulmonari
caviti
nodul
consid
hallmark
coccidiomycosi
immunocompromis
patient
especi
high
risk
dissemin
diseas
manifest
plaqu
papul
pustul
chronic
granulomat
mening
serolog
test
igm
use
precipitin
similar
test
complement
fixat
igg
skin
test
commonli
employ
diagnost
modal
treatment
ketoconazol
fluconazol
amphotericin
b
figur
definit
nosocomi
pneumonia
one
start
least
hour
hospit
admiss
nosocomi
pneumonia
hospitalacquir
pneumonia
main
caus
nosocomi
mortal
nosocomi
infect
result
death
due
nosocomi
pneumonia
patient
hospit
stroke
develop
pneumonia
increas
risk
death
threefold
develop
nosocomi
pneumonia
increas
length
hospit
stay
averag
day
cost
treat
hospitalacquir
pneumonia
rang
patient
treat
ward
per
case
ventilatorassoci
pneumonia
treat
icu
drugresist
pathogen
increasingli
account
communityand
hospitalacquir
pneumonia
need
infecti
diseas
id
servic
consult
subject
providerspecif
institut
restrict
antibiot
formulari
may
necessari
obtain
id
approv
use
specif
antibiot
approv
synonym
formal
id
consult
id
consult
might
consid
highrisk
circumst
immunosuppress
patient
patient
complic
histori
frequent
infect
risk
pathogen
resist
high
situat
patient
condit
worsen
despit
aggress
antibiot
therapi
nosocomi
pneumonia
often
divid
hospitalacquir
pneumonia
hap
nosocomi
pneumonia
develop
patient
mechan
ventil
either
ward
icu
ventilatorassoci
pneumonia
vap
occur
patient
receiv
mechan
ventil
vap
usual
refer
patient
icu
vap
may
occur
also
patient
receiv
chronic
mechan
ventil
outsid
icu
hap
incid
hospit
admiss
pneumonia
second
common
caus
account
bacteremia
sepsi
hospit
patient
risk
factor
includ
advanc
age
malnutrit
obes
impair
immun
depress
level
conscious
prior
surgeri
hap
due
anaerob
consid
primarili
set
recent
abdomin
surgeri
anaerob
infect
suspect
aspir
patient
admit
pneumonia
commun
come
institution
set
recent
hospit
treat
though
hap
sever
hap
defin
base
admiss
icu
respiratori
failur
base
need
fio
maintain
spo
need
mechan
ventil
rapid
radiolog
progress
lung
infiltr
evid
sever
sepsi
hypotens
andor
endorgan
dysfunct
core
pathogen
hap
aureu
pneumonia
enter
gramneg
bacilli
egnb
treatment
earlyonset
hap
must
provid
coverag
core
pathogen
recommend
regimen
treatment
hap
includ
ceftriaxon
cefuroxim
cefotaxim
macrolid
howev
antimicrobi
resist
develop
rapidli
monotherapi
fourthgener
cephalosporin
may
costeffect
therapi
hap
hap
aureu
pneumonia
due
methicillinoxacillinresist
aureu
mrsaorsa
strain
like
requir
vancomycin
linezolid
zyvox
effect
therapi
legionella
opportunist
aspergillu
suspect
hap
set
administr
highdos
steroid
new
onset
worsen
pulmonari
symptom
hospit
patient
endem
aspergillu
infect
recent
relat
hospit
construct
renov
immunocompromis
critic
ill
patient
expos
construct
dust
nosocomi
pneumonia
develop
least
hour
initi
mechan
ventil
known
vap
nosocomi
pneumonia
accru
approxim
adult
icu
patient
incid
time
greater
nonicu
patient
approxim
nosocomi
pneumonia
occur
hospit
patient
receiv
mechan
ventil
vap
incid
patient
receiv
shortterm
mechan
ventil
cumul
incid
vap
increas
number
ventil
day
statist
increment
risk
develop
vap
mechan
ventil
rang
per
day
clinic
diagnosi
rel
poor
indic
nosocomi
pneumonia
chest
radiographi
also
nonspecif
empir
therapi
nosocomi
pneumonia
must
provid
adequ
coverag
core
organ
respons
major
nosocomi
pneumonia
given
institut
antibiogram
compil
statist
regard
antibiot
efficaci
profil
pathogen
given
institut
must
also
consult
strategi
decreas
incid
nosocomi
pneumonia
includ
use
routin
infectioncontrol
practic
vigor
handwash
decontamin
equip
hospit
staff
nutrit
assess
support
isol
patient
resist
respiratori
pathogen
import
risk
factor
vap
includ
emerg
surgeri
intub
recumb
posit
oral
pharyng
secret
preexist
cardiopulmonari
neurolog
diseas
sever
ill
tracheostomi
durat
mechan
ventil
administr
system
glucocorticoid
independ
predict
risk
vap
patient
requir
emerg
intub
emerg
reintub
receiv
tracheostomi
higher
risk
develop
vap
occult
vap
common
caus
failur
wean
mechan
ventil
endotrach
tube
predispos
pneumonia
format
bypass
normal
filter
mechan
upper
airway
provid
direct
conduit
aspir
pathogen
lower
respiratori
tree
shown
impair
mucociliari
clearanc
epitheli
ciliari
function
rapidli
develop
contamin
biofilm
mechan
introduc
distal
routin
suction
endotrach
tube
cuff
interfer
deglutit
also
promot
pool
oral
pharyng
secret
endotrach
tube
cuff
highvolum
lowpressur
endotrach
tube
cuff
use
clinic
practic
complet
occlud
upper
airway
therefor
prevent
either
gross
aspir
syndrom
microaspir
oral
pharyng
secret
vap
similar
nosocomi
infect
must
manag
especi
aggress
patient
implant
foreign
bodi
vascular
graft
materi
arthroplasti
pacemak
defibril
virul
nosocomi
pathogen
potenti
immunolog
compromis
inpati
make
hematogen
seed
foreign
bodi
especi
like
thereaft
difficult
treat
vap
also
character
base
time
onset
pneumonia
earlyonset
vap
occur
within
first
hour
initi
mechan
ventil
commonli
attribut
antibioticsensit
organ
aureu
h
influenza
pneumonia
egnb
tabl
lateonset
vap
pneumonia
diagnos
hour
initi
mechan
ventil
typic
caus
mrsa
orsa
p
aeruginosa
enterobact
spp
acinetobact
spp
organ
like
resist
contribut
morbid
mortal
therefor
key
core
pathogen
vap
gener
p
aeruginosa
pneumonia
acinetobact
spp
aureu
egnb
vap
polymicrobi
approxim
time
empir
antibiot
therapi
vap
must
account
aggress
combin
therapi
base
antibiogram
specif
icu
well
criteria
durat
therapi
microbiolog
data
becom
avail
usual
within
hour
empir
therapi
taper
modifi
accordingli
key
dilemma
diagnosi
vap
differenti
endotrach
tube
colon
airway
colon
bronchiti
true
pneumonia
colon
defin
persist
microorgan
anatom
site
without
evid
host
respons
local
invas
differenti
pneumonia
colon
especi
difficult
diagnosi
base
nonquantit
cultur
obtain
simpl
endotrach
tube
suction
varieti
microorgan
normal
colon
upper
respiratori
tract
includ
viridan
streptococci
streptococcu
pyogen
neisseria
spp
moraxella
corynebacterium
lactobacillu
candida
spp
aureu
extrem
common
caus
communityand
hospitalacquir
pneumonia
howev
hospit
endem
rate
colon
high
make
almost
ubiquit
hospit
pathogen
mrsa
orsa
account
hospit
isol
aureu
resist
function
alter
penicillin
bind
protein
confer
betalactam
resist
well
target
modif
confer
macrolid
possibl
fluoroquinolon
resist
vancomycin
becom
mainstay
therapi
aureu
emerg
vancomycinresist
aureu
vrsa
vancomycin
glycopeptid
intermediatesensit
aureu
visa
gisa
increasingli
requir
complex
therapi
agent
quinupristindafopristin
synercid
linezolid
gramneg
pathogen
account
approxim
clinic
laboratori
isol
patient
nosocomi
pneumonia
enterobacteriacea
speci
commonli
seen
includ
k
pneumonia
proteu
spp
serratia
spp
citrobact
spp
escherichia
spp
agent
resist
betalactam
product
batalactamas
howev
extendedspectrum
betalactamas
esbl
betalactamas
resist
betalactamas
inhibitor
inhibitorresist
temderiv
beta
lactamas
becom
signific
faecium
e
faecali
becom
seriou
threat
howev
former
vastli
common
latter
present
time
linezolid
synercid
import
antibiot
class
organ
staphylococcu
reflect
overus
estim
vancomycin
use
inappropri
pseudomona
aeruginosa
extrem
common
pathogen
hap
vap
higher
mortal
rate
gramneg
bacilli
plasmidmedi
resist
rapid
pseudomona
pneumonia
increas
icu
mortal
factor
patient
p
aeruginosa
acinetobact
infect
crude
icu
mortal
exce
fungal
pneumonia
underdiagnos
undertr
critic
ill
patient
mycot
infect
known
occur
presenc
adjunct
antibiot
therapi
immunosuppress
sever
ill
unfortun
fungal
infect
like
postmortem
diagnosi
clinic
one
key
limit
inabl
cultur
rapidli
specimen
contain
fungal
pathogen
perform
sensit
test
isol
develop
antifung
agent
decreas
system
toxic
facilit
treatment
mycos
critic
ill
patient
specif
criteria
initi
discontinu
system
fungal
agent
remain
controversi
gold
standard
method
diagnosi
vap
studi
repeatedli
unabl
demonstr
statist
signific
clear
valu
techniqu
howev
number
diagnost
modal
use
practic
endotrach
tube
aspir
eta
bronchoscopedirect
protect
brush
bdpb
protect
brush
specimen
pb
bronchoscop
bronchoalveolar
lavag
bbal
blind
bal
qtl
quantit
tracheal
lavag
techniqu
endotrach
tube
aspir
commonli
perform
method
cultur
respiratori
secret
sinc
endotrach
tube
aspir
cultur
contamin
colon
well
infecti
pneumonia
use
semiquantit
cultur
determin
sputum
neutrophil
count
greatli
increas
sensit
bronchoscopi
import
adjunct
diagnosi
vap
give
direct
visual
airway
reveal
inflamm
mucu
mucu
plug
protect
brush
specimen
obtain
either
blindli
bronchoscop
protect
brush
design
reduc
fals
posit
cultur
due
contamin
upper
airway
secret
may
repres
tracheobronch
rather
true
pneumonia
protect
brush
hous
within
close
cannula
cannula
pass
distal
airway
brush
advanc
occlud
plug
cannula
expos
directli
distal
respiratori
secret
structur
retract
cannula
remov
plate
cultur
quantit
cultur
reveal
coloni
growth
coloni
form
unit
cfu
ml
consid
posit
correspond
bacteri
densiti
cfuml
undilut
respiratori
secret
bronchoalveolar
lavag
perform
bronchoscop
wash
specif
lung
segment
isoton
salin
collect
effluent
directli
bronchoscop
suction
cultur
bal
perform
use
wedg
cathet
tip
isol
lung
segment
lavag
techniqu
known
protect
bal
minimum
lavag
volum
approxim
ml
recommend
adequ
sampl
smaller
volum
salin
ml
use
techniqu
call
minib
threshold
cfuml
consid
posit
pneumonia
bal
use
correspond
bacteri
titer
undilut
respiratori
secret
protect
brush
sensit
specif
bal
consid
rang
open
lung
biopsi
definit
diagnost
procedur
histopatholog
diagnosi
pneumonia
immunocompromis
host
risk
undertreat
increas
morbid
mortal
risk
overtreat
includ
develop
resist
strain
bacteria
signific
cost
continu
surveil
cultur
medic
consult
drug
level
monitor
increas
potenti
medic
error
singl
best
predictor
mortal
patient
vap
resolut
pulmonari
shunt
measur
pao
fio
ratio
success
prevent
vap
clearli
costeffect
strategi
surveil
treatment
avoid
patient
crosscontamin
vigor
handwash
probabl
import
precaut
health
care
worker
take
prevent
spread
pneumonia
infect
hospit
univers
precaut
consid
univers
use
endotrach
tube
design
permit
continu
remov
pool
subglott
secret
proven
decreas
incid
vap
pleural
parapneumon
effus
associ
bacteri
pneumonia
effus
free
locul
may
either
resolv
develop
empyema
effus
drain
immedi
radiolog
evid
airfluid
level
parapneumon
effus
evalu
paracentesi
gram
stain
cultur
ph
ldh
protein
glucos
order
differenti
transud
exud
fluid
grossli
purul
fluid
drain
clinic
pulmonari
infect
score
cpi
util
detect
onset
vap
also
determin
suffici
adequaci
treatment
cpi
also
correl
mortal
diagnosi
pneumonia
gener
base
upon
variat
cpi
origin
develop
pugin
et
al
tabl
cpi
specif
similar
bronchoscop
diagnosi
pneumonia
key
paramet
includ
temperatur
quantiti
secret
leukocyt
count
chest
radiograph
find
hypoxemia
bal
gram
stain
cultur
cpi
indic
infecti
pneumonia
sensit
specif
therefor
cpi
almost
exclud
acut
lung
injuri
pulmonari
edema
atelectasi
etiolog
pulmonari
infiltr
caus
pneumonia
immunocompromis
host
includ
pathogen
list
extend
opportunist
pathogen
caus
pulmonari
infect
immunocompromis
patient
includ
mycobacterium
tuberculosi
aviumintracellular
cryptococcu
toxoplasma
cytomegaloviru
mani
infect
also
involv
organ
brain
eye
figur
pneumonia
immunocompromis
patient
present
atyp
dyspnea
hypoxemia
nonproduct
cough
gener
radiograph
infiltr
frequent
constitut
present
pictur
patient
may
hypotherm
rather
febril
may
leukopenia
rather
leukocytosi
respons
pathogen
may
isol
immunocompromis
patient
earli
evolut
system
sepsi
popul
make
rapid
diagnosi
intervent
extrem
import
pneumocysti
carinii
pcp
protozoan
pneumonia
common
hivinfect
patient
pneumonia
patient
posit
semirecumb
rather
supin
posit
decreas
incid
vap
elev
head
patient
bed
decreas
risk
aspir
controversi
strategi
includ
stress
ulcer
prophylaxi
select
digest
decontamin
aggress
oral
dental
care
frequent
chang
ventil
circuit
filter
potenti
futur
develop
includ
use
bioactiv
drugimpregn
biomateri
endotrach
tube
construct
rapidli
progress
lethal
classic
ground
glass
appear
chest
radiograph
nonspecif
may
repres
earli
ard
initi
antibiot
choic
pcp
trimethoprimsulfamethoxazol
tmpsmx
coadministr
steroid
must
consid
initi
respons
therapi
frequent
clinic
deterior
may
requir
intub
mechan
ventil
treatment
tmpsmx
consid
fail
favor
respons
appar
within
three
five
day
secondlin
agent
intraven
pentamidin
pentamidin
associ
signific
side
effect
includ
qtc
prolong
torsad
de
point
renal
insuffici
pancreat
neutropenia
well
hyperand
hypoglycemia
figur
patient
sever
infect
process
support
therapi
necessari
prevent
secondari
injuri
develop
complic
fluid
resuscit
basic
tenet
manag
infect
mani
patient
unabl
drink
plenti
fluid
therefor
requir
intraven
hydrat
system
infect
system
inflammatori
respons
produc
earli
peripher
vasodilat
capillari
leak
result
diminish
intravascular
fluid
volum
sinc
increas
stroke
volum
usual
possibl
patient
decreas
intravascular
volum
initi
compens
tachycardia
maintain
cardiac
output
oxygen
deliveri
tissu
patient
unabl
mount
compensatori
tachycardia
diabet
myocardi
pump
dysfunct
betablock
therapi
etc
earli
sign
diminish
peripher
perfus
shock
set
prolong
underresuscit
inflammatori
cascad
activ
region
hypoperfus
result
acidosi
elev
serum
lactat
acut
renal
failur
due
acut
tubular
necrosi
region
underperfus
result
patient
becom
progress
difficult
resuscit
later
vasopressor
use
mainstay
therapi
sepsi
although
vasopressor
may
use
tempor
fluid
resuscit
ongo
substitut
vasopressor
fluid
result
progress
tissu
ischemia
organ
failur
develop
progress
hypoxemia
intravascular
volum
therapi
necessarili
mean
intravascular
fluid
overload
also
consist
worsen
pneumonia
interv
develop
ard
data
support
use
colloid
crystalloid
intravascular
volum
resuscit
howev
emerg
data
may
suggest
judici
use
colloid
may
help
maintain
intravascular
oncot
pressur
decreas
edema
format
intravascular
volum
replac
therapi
titrat
urin
output
sign
improv
organ
perfus
mental
statu
cyanosi
resolut
etc
serum
lactat
acidbas
balanc
central
venou
fill
preload
measur
correl
cardiac
output
echocardiograph
determin
end
systol
volum
cardiac
perform
histori
poor
cardiac
function
congest
heart
failur
pulmonari
edema
contraind
intravascular
volum
replac
patient
sever
infect
highli
catabol
nutrit
support
institut
immedi
possibl
mani
patient
pneumonia
alreadi
nutrit
deplet
initi
present
baselin
nutrit
statu
prealbumin
transferrin
document
daili
calori
count
serial
nutrit
indic
may
requir
ensur
adequaci
nutrit
support
unless
definit
contraind
enter
feed
rout
choic
nutrit
support
nutrit
deplet
shown
increas
bacteri
adher
airway
reduc
alveolar
macrophag
function
impair
neutrophil
macrophag
recruit
decreas
level
circul
complement
factor
reduc
level
airway
iga
abil
antibiot
exert
pharmacolog
effect
relat
penetr
infect
tissu
achiev
adequ
tissu
concentr
inappropri
treatment
pneumonia
often
due
either
nonsuscept
resist
pathogen
chosen
antibiot
regimen
inappropri
initi
antibiot
select
rang
dramat
impact
outcom
measur
length
stay
multipl
organ
dysfunct
syndrom
mortal
antibiot
good
penetr
respiratori
secret
depend
local
inflamm
includ
quinolon
azithromycin
clarithromycin
tetracyclin
clindamycin
tmpsmx
antibiot
impair
penetr
respiratori
secret
andor
depend
inflamm
concentr
within
lung
tissu
includ
aminoglycosid
betalactam
penicillin
cephalosporin
carbapenem
aminoglycosid
poor
pulmonari
penetr
especi
penetr
well
respiratori
secret
therefor
aminoglycosid
upright
anteroposterior
ap
view
widespread
bilater
interstiti
alveolar
infiltr
resembl
ard
interstiti
mark
result
honeycomb
appear
endotrach
tube
present
use
monotherapi
gramneg
pneumonia
azithromycin
replac
erythromycin
clinic
practic
erythromycin
side
effect
qtc
prolong
well
enter
prokinesi
caus
cramp
discomfort
fluoroquinolon
also
associ
qtc
prolong
especi
higher
dose
pathogen
suscept
often
report
term
minimum
inhibitori
concentr
mic
agent
choic
therefor
depend
mic
guidelin
restrict
cost
optim
pharmacolog
action
antibiot
everi
concentrationdepend
mechan
action
occur
c
max
mic
greater
patient
fail
respond
clinic
hour
antimicrobi
therapi
therapeut
strategi
must
reevalu
gener
requir
workup
includ
revalu
cultur
sensit
data
consider
superinfect
reconsider
drug
dose
rout
administr
consider
altern
diagnosi
evalu
patient
immunolog
statu
may
also
necessari
rout
antibiot
therapi
may
import
care
icu
patient
inhal
antibiot
therapi
probabl
underutil
inhal
antibiot
consid
sever
hap
treatment
refractori
pneumonia
popul
patient
cystic
fibrosi
mechan
antimicrobi
resist
includ
targetmedi
resist
enzymat
inactiv
cell
membran
permeabl
alter
activ
expuls
antibiot
bacteri
cell
targetmedi
resist
result
alter
number
affin
antimicrobi
bind
site
within
bacteria
enzymat
inactiv
result
product
bacteri
enzym
often
carri
plasmid
degrad
antibiot
agent
betalactamas
product
common
form
enzymat
resist
cell
membran
permeabl
chang
caus
decreas
antimicrobi
uptak
bacteri
cell
promot
activ
reflux
antibiot
bacteri
cell
energydepend
mechan
carri
plasmid
creation
molecul
known
transposon
rotat
firstlin
antibiot
choic
demonstr
decreas
rate
evolut
pathogen
resist
therefor
choic
antibiot
also
made
accord
prefer
antibiot
particular
cycl
particular
hospit
rare
case
use
immunomodulatori
agent
granulocyt
colonystimul
factor
gcsf
may
need
consid
enhanc
host
polymorphonuclear
leukocyt
pmn
respons
bronchodil
import
adjunct
therapi
patient
reactiv
airway
diseas
develop
superimpos
respiratori
tract
infect
sinc
airway
infect
predispos
patient
bronchospasm
therebi
interfer
abil
cough
clear
secret
bronchodil
therapi
benefici
popul
patient
use
bronchodil
therapi
regularli
prior
admiss
may
requir
increas
dose
frequenc
nonsteroid
bronchodil
either
agonist
albuterol
anticholinerg
atrov
sympathomimet
still
precipit
tachycardia
levalbuterol
select
isom
significantli
less
cardiac
activ
possibl
also
longer
effect
halflif
steroid
import
bronchodil
patient
underli
chronic
obstruct
pulmonari
diseas
copd
sever
reactiv
airway
diseas
methylprednisolon
intraven
steroid
bronchodil
choic
prednison
administ
enter
patient
steroid
chronic
prescrib
prior
admiss
requir
supplement
stress
dose
avoid
adren
insuffici
set
infecti
stress
mucolyt
agent
expector
may
role
mucu
clearanc
difficult
set
dehydr
inspiss
mucu
difficult
patient
clear
nacetylcystein
recombin
dnase
guaifenesin
prototyp
mucolyt
agent
nacetylcystein
precipit
bronchospasm
administ
concomitantli
bronchodil
humidif
inspir
gase
import
endotrach
tube
bypass
normal
humidif
filter
system
upper
airway
humidif
import
avoid
dri
mucos
surfac
patient
inflam
upper
airway
humidif
improv
expector
lower
airway
secret
hand
humidif
system
must
care
monitor
contamin
hypophil
organ
pseudomona
legionella
stress
ulcer
prophylaxi
must
consid
hospit
critic
ill
patient
expos
metabol
stress
stress
ulcer
prophylaxi
shown
decreas
incid
gastrointestin
bleed
standard
care
hypothesi
increas
gastric
ph
stress
ulcer
prophylaxi
increas
incid
nosocomi
pneumonia
due
aspir
colon
gastric
content
longer
favor
commonli
use
agent
includ
proton
pump
inhibitor
pantoprazol
other
h
blocker
famotidin
barrier
agent
sucralf
use
oral
care
agent
topic
mycostatin
liquid
may
benefici
focus
attent
oral
care
potenti
bacteri
fungal
overgrowth
oral
pharynx
integr
patient
decreas
salivari
product
clearanc
also
oral
care
agent
may
antisept
effect
decreas
bacteri
colon
patient
develop
perior
intraor
herpet
vesicl
topic
antivir
agent
acyclovir
appli
although
pulmonari
arteriolar
vasodil
prostacyclin
pgi
nitric
oxid
use
manag
sever
case
pneumonia
use
costli
agent
remain
controversi
variabl
effect
hypox
pulmonari
vasoconstrict
hpv
adapt
respons
wherebi
reflex
vasoconstrict
arteriolar
suppli
inflam
diseas
alveoli
low
alveolar
oxygen
concentr
result
minim
pulmonari
shunt
fraction
therefor
pulmonari
arteriolar
vasodil
inhibit
hpv
respons
like
increas
blood
suppli
diseas
hypox
alveoli
actual
increas
shunt
fraction
system
hypoxemia
portabl
anteriorposterior
ap
chest
radiograph
commonli
obtain
radiolog
studi
icu
although
critic
care
practition
expect
render
complet
final
radiolog
read
incumb
intensivist
abl
reliabl
independ
render
preliminari
interpret
address
specif
question
regard
patient
clinic
condit
chest
radiograph
also
key
evalu
patient
respons
therapi
critic
care
note
reflect
independ
read
well
later
confirm
variat
seen
radiologist
endotrach
tube
midway
clavicl
carina
within
trachea
import
note
endotrach
tube
move
approxim
cm
trachea
extens
flexion
neck
respect
ii
nasogastr
feed
tube
must
follow
within
esophagu
stomach
small
bowel
tube
enter
trachea
often
pass
one
mainstem
bronchu
iii
tube
thoracostomi
mention
usual
made
posit
tube
intraor
extrathorac
placement
last
collect
hole
chest
tube
resolut
liquid
air
collect
tube
intend
treat
iv
hardwar
tracheostomi
tube
pacemak
implant
cardiac
defibril
wire
intraaort
balloon
pump
tip
prosthet
cardiac
valv
evid
vascular
prosthes
stent
sternal
wire
surgic
clip
orthoped
prosthes
airway
stent
mention
foreign
bodi
especi
trauma
case
particularli
import
c
boni
structur
fractur
disloc
clavicl
sternum
scapula
rib
vertebra
ii
hyperostosi
osteopenia
potenti
boni
involv
surround
tumor
infect
cardiovascular
silhouett
ap
portabl
radiograph
unreli
indic
cardiomegali
ii
cardiac
silhouett
iii
thorac
aorta
special
mention
made
calcif
within
thorac
aorta
dilat
thorac
aorta
iv
pulmonari
vasculatur
hilar
accentu
pulmonari
arteriol
seen
endon
usual
appar
present
small
opaqu
circl
hilar
region
normal
find
evid
vascular
promin
interstiti
promin
alveolar
flood
consist
stage
congest
heart
failur
pulmonari
edema
respect
must
note
